• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 危机期间健康科学研究的障碍和促进因素:范围综述。

Health science research barriers and facilitators in the midst of the COVID-19 crisis: scoping review.

机构信息

Instituto de Investigaciones Clínicas, Universidad Nacional de Colombia, Bogotá (Colombia)..

Investigadora asociada Instituto de Investigaciones Clínicas, Universidad Nacional de Colombia, Bogotá (Colombia)..

出版信息

Rev Colomb Obstet Ginecol. 2021 Dec 30;72(4):377-395. doi: 10.18597/rcog.3788.

DOI:10.18597/rcog.3788
PMID:35134285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8833242/
Abstract

OBJECTIVE

The COVID-19 pandemic has imposed a great challenge on health research because of the pressing need to respond promptly and effectively to this crisis situation. It is important to offer a high level perspective of the main barriers and facilitators found when conducting health science studies during the COVID-19 crisis and to discuss the research initiatives suggested by global, regional or local health research authorities.

MATERIALS AND METHODS

A systematic scoping review was carried out. A literature search was conducted in the Medline, Cochrane Library, Lilacs and Google Scholar databases. Original research studies, review and opinion articles and editorials available in full text published in Spanish, English or Portuguese between January 2020 and May 2021 were included. Two authors working independently selected the papers and collected the data. The barriers and facilitators identified were described and organized in four categories according to the literature: sociocultural, administrative, organizational and methodological. Official documents and communications from global, regional and local health and research authorities were also included. Results are presented in narrative and table form.

RESULTS

Overall, 26 documents were selected for data analysis and synthesis. The barriers most frequently mentioned in the literature include issues with access to participants, ethics committees paperwork, biological risk for the researchers, and lack of inter and intra-institutional coordination. On the other hand, the facilitators identified include the adoption of on-line solutions, cooperative work among research actors, and a more flexible informed consent process. Regarding the initiatives disseminated by health and research authorities, four strategies were identified: prioritization of research questions, cooperation and inclusion promotion, fight against infodemia, and strengthening of the methodological quality of the studies.

CONCLUSIONS

Continued cooperation and interoperability among institutions, countries and disciplines to facilitate future research processes is a challenge in the context of the pandemic; similarly, it is now important to maintain open science and funding of cooperative studies when other priorities emerge. Likewise, there is an evident need to develop and sustain efficient information management systems to help with decision-making. Ongoing review of the effects of the pandemic on health research practice is needed in order to gain comprehensive insights of what we need to learn as a society from this crisis.

摘要

目的

由于需要迅速有效地应对这一危机情况,新冠疫情对卫生研究提出了巨大挑战。提供在新冠疫情危机期间进行卫生科学研究时发现的主要障碍和促进因素的高层次视角,并讨论全球、区域或地方卫生研究当局提出的研究倡议,这一点很重要。

材料与方法

本研究进行了系统的范围界定。在 Medline、Cochrane 图书馆、Lilacs 和 Google Scholar 数据库中进行了文献检索。纳入了 2020 年 1 月至 2021 年 5 月期间以西班牙语、英语或葡萄牙语全文发表的原始研究、综述和观点文章以及社论。两名独立工作的作者选择论文并收集数据。根据文献,将识别出的障碍和促进因素描述并分为四类:社会文化、行政、组织和方法。还包括来自全球、区域和地方卫生和研究当局的官方文件和通讯。结果以叙述和表格形式呈现。

结果

总体而言,有 26 份文件被选入进行数据分析和综合。文献中最常提到的障碍包括参与者准入问题、伦理委员会文件工作、研究人员的生物风险以及机构间和机构内协调不足。另一方面,确定的促进因素包括采用在线解决方案、研究人员之间的合作、以及更灵活的知情同意程序。关于卫生和研究当局传播的倡议,确定了四项策略:优先考虑研究问题、促进合作和包容、抗击信息泛滥、以及加强研究方法质量。

结论

在大流行背景下,机构、国家和学科之间继续合作和互操作以促进未来的研究过程是一项挑战;同样,当出现其他优先事项时,现在需要保持开放科学和合作研究的资金。同样,显然需要开发和维持高效的信息管理系统,以帮助决策。需要对大流行对卫生研究实践的影响进行持续审查,以便全面了解我们作为一个社会从这场危机中需要吸取的经验教训。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b18/8833242/22714f0d675e/2463-0225-rcog-72-04-3788-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b18/8833242/22714f0d675e/2463-0225-rcog-72-04-3788-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b18/8833242/22714f0d675e/2463-0225-rcog-72-04-3788-gf1.jpg

相似文献

1
Health science research barriers and facilitators in the midst of the COVID-19 crisis: scoping review.COVID-19 危机期间健康科学研究的障碍和促进因素:范围综述。
Rev Colomb Obstet Ginecol. 2021 Dec 30;72(4):377-395. doi: 10.18597/rcog.3788.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
4
Interventions to support the resilience and mental health of frontline health and social care professionals during and after a disease outbreak, epidemic or pandemic: a mixed methods systematic review.在疾病爆发、流行或大流行期间及之后,为支持一线卫生和社会护理专业人员的适应能力和心理健康所采取的干预措施:一项混合方法的系统评价
Cochrane Database Syst Rev. 2020 Nov 5;11(11):CD013779. doi: 10.1002/14651858.CD013779.
5
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.从婴儿和新生儿获取器官或组织用于移植、研究或商业目的的伦理问题:生物伦理学范围审查方案
Wellcome Open Res. 2024 Dec 5;9:717. doi: 10.12688/wellcomeopenres.23235.1. eCollection 2024.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Unintended consequences of measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.学校为遏制新冠疫情而采取的措施所产生的意外后果:一项范围综述。
Cochrane Database Syst Rev. 2024 Dec 12;12(12):CD015397. doi: 10.1002/14651858.CD015397.pub2.
8
Public sector reforms and their impact on the level of corruption: A systematic review.公共部门改革及其对腐败程度的影响:一项系统综述。
Campbell Syst Rev. 2021 May 24;17(2):e1173. doi: 10.1002/cl2.1173. eCollection 2021 Jun.
9
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
10
Health research mentorship in low- and middle-income countries: a scoping review.健康研究指导在中低收入国家:范围综述。
JBI Evid Synth. 2023 Oct 1;21(10):1912-1970. doi: 10.11124/JBIES-22-00260.

本文引用的文献

1
The time is now: role of pragmatic clinical trials in guiding response to global pandemics.现在是时候了:实用临床试验在指导应对全球大流行中的作用。
Trials. 2021 Mar 24;22(1):229. doi: 10.1186/s13063-021-05165-0.
2
Clinical Trial Data Sharing for COVID-19-Related Research.COVID-19 相关研究的临床试验数据共享。
J Med Internet Res. 2021 Mar 12;23(3):e26718. doi: 10.2196/26718.
3
Impact of the COVID-19 pandemic on clinical research in hospitals: observational study in the first epicenter of the epidemic during the general lockdown in France.
COVID-19 大流行对医院临床研究的影响:法国全面封锁期间疫情首发地的观察性研究。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):1158-1162. doi: 10.26355/eurrev_202101_24686.
4
An ethics framework for consolidating and prioritizing COVID-19 clinical trials.用于整合和优先考虑 COVID-19 临床试验的伦理框架。
Clin Trials. 2021 Apr;18(2):226-233. doi: 10.1177/1740774520988669. Epub 2021 Feb 2.
5
Impact of the coronavirus (COVID-19) pandemic on scientific research and implications for clinical academic training - A review.冠状病毒(COVID-19)大流行对科学研究的影响及其对临床学术培训的影响-综述。
Int J Surg. 2021 Feb;86:57-63. doi: 10.1016/j.ijsu.2020.12.008. Epub 2021 Jan 12.
6
Research in the Time of COVID-19: Challenges of Research Ethics Committees.新冠疫情时代的研究:研究伦理委员会面临的挑战
J ASEAN Fed Endocr Soc. 2020;35(1):29-32. doi: 10.15605/jafes.035.01.07. Epub 2020 May 23.
7
Obstacles and Considerations Related to Clinical Trial Research During the COVID-19 Pandemic.2019年冠状病毒病大流行期间与临床试验研究相关的障碍和考量因素
Front Med (Lausanne). 2020 Dec 23;7:598038. doi: 10.3389/fmed.2020.598038. eCollection 2020.
8
The landscape of COVID-19 clinical trials in Latin America and the Caribbean: assessment and challenges.拉丁美洲和加勒比地区的新冠病毒临床试验概况:评估与挑战
Rev Panam Salud Publica. 2020 Dec 23;44:e177. doi: 10.26633/RPSP.2020.177. eCollection 2020.
9
Ethical considerations of the dynamics of clinical trials in an epidemic context: Studies on COVID-19.疫情背景下临床试验动态的伦理考量:关于新冠病毒病的研究
Ethics Med Public Health. 2021 Mar;16:100621. doi: 10.1016/j.jemep.2020.100621. Epub 2020 Dec 16.
10
Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?从 COVID-19 疫情中吸取的意大利临床研究运营经验:我们学到了什么,未来可以应用哪些经验?
Tumori. 2021 Feb;107(1):6-11. doi: 10.1177/0300891620977916. Epub 2020 Dec 9.